← Issue №20/ week of Nov 15, 2026/Hepatology

Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.

From GI Signals issue №20: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology retrospective · n=108 · Nov 14, 2026 · Dig Liver Dis · IF 4.2

Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.

New evidenceascitescirrhosis
Clinical takeawayHigh serum urea, high neutrophil count and low platelet count marked higher 30-day mortality risk in SFP; antifungal timing and choice were not studied, and non-albicans Candida showed notable azole resistance.
What it foundSpontaneous fungal peritonitis (SFP) had higher mortality than fungiascites (29.8% vs 13.7%, p=0.045) and spontaneous bacterial peritonitis (29.8% vs 7.0%, p=0.002). A nomogram incorporating serum urea (>18 mmol/L), neutrophil count (>10 × 109/L), and platelet count (<75 × 109/L) may facilitate early assessment of 30-day mortality.
ContextThis study highlights the poorer prognosis of SFP compared to bacterial ascitic infections, refining the understanding of fungal ascitic infections in cirrhosis.
Emergingsuggested applicable standard· American Association for the Study of Liver Diseases, 'Guidelines on the Management of Adult Patients with Ascites Due to Cirrhosis', 2021

Perform diagnostic paracentesis in any cirrhotic with ascites and infection risk; an ascitic PMN ≥250 cells/μL diagnoses SBP and mandates empiric IV antibiotics ASAP, ceftriaxone 2 g IV daily for community-acquired disease (broader pip-tazo/carbapenem for nosocomial). Administer albumin (1.5 g/kg day 1, 1 g/kg day 3) to patients with serum creatinine >1 mg/dL, BUN ≥30 mg/dL, or bilirubin ≥4 mg/dL to reduce HRS and mortality. Confirm response with a repeat paracentesis at 48 h (adequate = PMN drop ≥25%), distinguish secondary peritonitis by Runyon criteria, and start indefinite secondary prophylaxis (norfloxacin/ciprofloxacin/TMP-SMX) after an episode.

American Association for the Study of Liver Diseases, 'Guidelines on the Management of Adult Patients with Ascites Due to Cirrhosis', 2021 · reviewed 2026-07-21 ↗
Li X … Huang L · Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · IF 4.2 · PubMed ↗Permalink
← Read the whole of issue №20 Every paper GI Signals surfaces gets a page like this one. All issues